Therapeutic Effect of Ginsenoside Rd on Experimental Autoimmune Encephalomyelitis Model Mice: Regulation of Inflammation and Treg/Th17 Cell Balance

Figure 1

Treatment with Ginsenoside Rd ameliorated the clinical severity of experimental autoimmune encephalomyelitis (EAE) mice. Following immunization and treatment with Ginsenoside Rd, daily clinical scores of EAE mice with or without Ginsenoside Rd treatment were recorded over the course of the 35-day experiment: (a) daily clinical scores of EAE mice with or without Ginsenoside Rd treatment; (b) mean clinical scores of EAE mice with or without Ginsenoside Rd treatment; (c) cumulative clinical scores of EAE mice with or without Ginsenoside Rd treatment. , vs. EAE group. Gin Rd: Ginsenoside Rd.

(a)

(b)

(c)